Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerard F Anderson

Showing results (101-110 of 167) with videos related to

Pageof 17
Sort By:
Journal of Managed Care & Specialty Pharmacy|December 23, 2023
Sociodemographic and spending characteristics of Medicare beneficiaries taking prescription drugs subject to price negotiationsIlina C Odouard, Gerard F Anderson, G Caleb Alexander, et al.
JAMA Health Forum|May 26, 2023
Comparison of Out-of-Pocket Spending on Ultra-Expensive Drugs in Medicare Part D vs Commercial InsuranceMichael J DiStefano, So-Yeon Kang, Sonal Parasrampuria, et al.
Health Affairs (Project Hope)|August 7, 2023
Hospital Prices For Commercial Plans Are Twice Those For Medicare Advantage Plans When Negotiated By The Same InsurerMark Katz Meiselbach, Yang Wang, Jianhui Xu, et al.
The American Journal of Managed Care|April 11, 2024
Adjusting starting points for initial price offers: the example of ibrutinibJason B Gibbons, Charles L Bennett, Kenneth R Carson, et al.
Diabetes Care|March 5, 2002
Diabetes-related morbidity and mortality in a national sample of U.S. eldersAlain G Bertoni, Julie S Krop, Gerard F Anderson, et al.
Journal of Occupational and Environmental Medicine|December 6, 2014
Geographic variability of adherence to occupational injury treatment guidelinesAntonio J Trujillo, Sara E Heins, Gerard F Anderson, et al.
Population Health Management|December 28, 2020
Hospital Inpatient Charges of COVID-19 Diagnostic Tests Ranged from $10 to $1390Hossein Zare, Ge Bai, Corey Albrecht, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 9, 2023
Estimated Savings From Using Added Therapeutic Benefit and Therapeutic Reference Pricing in United States Medicare Drug Price NegotiationsMichael J DiStefano, Joseph F Levy, Ilina C Odouard, et al.
Health Affairs (Project Hope)|May 11, 2006
Health care spending and use of information technology in OECD countriesGerard F Anderson, Bianca K Frogner, Roger A Johns, et al.
JAMA|December 14, 2023
Spending on Dual Over-the-Counter and Prescription Drugs in the Medicare Part D ProgramMariana P Socal, Yuchen Wang, Elizabeth Plummer, et al.
Pageof 17

Showing results (101-110 of 167) with videos related to

Sort By:
Pageof 17
Journal of Managed Care & Specialty Pharmacy|December 23, 2023
Sociodemographic and spending characteristics of Medicare beneficiaries taking prescription drugs subject to price negotiationsIlina C Odouard, Gerard F Anderson, G Caleb Alexander, et al.
JAMA Health Forum|May 26, 2023
Comparison of Out-of-Pocket Spending on Ultra-Expensive Drugs in Medicare Part D vs Commercial InsuranceMichael J DiStefano, So-Yeon Kang, Sonal Parasrampuria, et al.
Health Affairs (Project Hope)|August 7, 2023
Hospital Prices For Commercial Plans Are Twice Those For Medicare Advantage Plans When Negotiated By The Same InsurerMark Katz Meiselbach, Yang Wang, Jianhui Xu, et al.
The American Journal of Managed Care|April 11, 2024
Adjusting starting points for initial price offers: the example of ibrutinibJason B Gibbons, Charles L Bennett, Kenneth R Carson, et al.
Diabetes Care|March 5, 2002
Diabetes-related morbidity and mortality in a national sample of U.S. eldersAlain G Bertoni, Julie S Krop, Gerard F Anderson, et al.
Journal of Occupational and Environmental Medicine|December 6, 2014
Geographic variability of adherence to occupational injury treatment guidelinesAntonio J Trujillo, Sara E Heins, Gerard F Anderson, et al.
Population Health Management|December 28, 2020
Hospital Inpatient Charges of COVID-19 Diagnostic Tests Ranged from $10 to $1390Hossein Zare, Ge Bai, Corey Albrecht, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 9, 2023
Estimated Savings From Using Added Therapeutic Benefit and Therapeutic Reference Pricing in United States Medicare Drug Price NegotiationsMichael J DiStefano, Joseph F Levy, Ilina C Odouard, et al.
Health Affairs (Project Hope)|May 11, 2006
Health care spending and use of information technology in OECD countriesGerard F Anderson, Bianca K Frogner, Roger A Johns, et al.
JAMA|December 14, 2023
Spending on Dual Over-the-Counter and Prescription Drugs in the Medicare Part D ProgramMariana P Socal, Yuchen Wang, Elizabeth Plummer, et al.
Pageof 17